Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415 · see citing works

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907 · see citing works

Planning chemical syntheses with deep neural networks and symbolic AI

Segler, M. H. S., Preuss, M., & Waller, M. P. (2018) · Nature · doi:10.1038/nature25978 · Cited by 1,847 · see citing works

Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2

Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., & Zuo, W. (2020) · doi:10.1101/2020.01.26.919985 · Cited by 860 · see citing works

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies

Sharma, A., Tiwari, S., Deb, M. K., & Marty, J. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106054 · Cited by 720 · see citing works

Family-wide Structural Analysis of Human Numb-Associated Protein Kinases

Sorrell, F. J., Szklarz, M., Azeez, K. R. A., et al. (2016) · Structure · doi:10.1016/j.str.2015.12.015 · Cited by 142 · see citing works

Chemistry and Biology of SARS-CoV-2

Dömling, A. S. S., & Gao, L. (2020) · Chem · doi:10.1016/j.chempr.2020.04.023 · Cited by 138 · see citing works

COVID-19 infection: the China and Italy perspectives

Chen, J., Lu, H., Melino, G., Boccia, S., Piacentini, M., Ricciardi, W., Wang, Y., Shi, Y., & Zhu, T. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2603-0 · Cited by 126 · see citing works

Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment

Pu, S., Xiao, F., Schor, S., Bekerman, E., Zanini, F., Barouch‐Bentov, R., Nagamine, C. M., & Einav, S. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.05.001 · Cited by 106 · see citing works

Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease

Potdar, A. A., Dube, S., Naito, T., Li, K., Botwin, G. J., Haritunians, T., Li, D., Casero, D., Yang, S., Bilsborough, J., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.10.041 · Cited by 88 · see citing works

Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients

Convertino, I., Tuccori, M., Ferraro, S., Valdiserra, G., Cappello, E., Focosi, D., & Blandizzi, C. (2020) · Critical Care · doi:10.1186/s13054-020-03020-3 · Cited by 55 · see citing works

Wuhan coronavirus 2019-nCoV – what we can find out on a structural bioinformatics level

Gruber, C. C., & Steinkellner, G. (2020) · Figshare · doi:10.6084/m9.figshare.11752749 · Cited by 13 · see citing works

COVID-19: consider cytokine storm syndromes and immunosuppression

Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664 · see citing works

The trinity of COVID-19: immunity, inflammation and intervention

Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360 · see citing works

The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China

Zhang, W., Zhao, Y., Zhang, F., Wang, Q., Li, T., Liu, Z., Wang, J., Qin, Y., Zhang, X., Yan, X., et al. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108393 · Cited by 1,266 · see citing works

COVID-19: combining antiviral and anti-inflammatory treatments

Stebbing, J., Phelan, A., Griffin, I., Tucker, C., Oechsle, O., Smith, D., & Richardson, P. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30132-8 · Cited by 1,117 · see citing works

Artificial intelligence in COVID-19 drug repurposing

Zhou, Y., Wang, F., Tang, J., Nussinov, R., & Cheng, F. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30192-8 · Cited by 636 · see citing works

Building a knowledge graph to enable precision medicine

Chandak, P., Huang, K., & Zitnik, M. (2023) · Scientific Data · doi:10.1038/s41597-023-01960-3 · Cited by 522 · see citing works

Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper

Boettler, T., Newsome, P. N., Mondelli, M. U., Maticic, M., Cordero, E., Cornberg, M., & Berg, T. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100113 · Cited by 477 · see citing works

COVID-19 infection and rheumatoid arthritis: Faraway, so close

Favalli, E. G., Ingegnoli, F., De Lucia, O., Cincinelli, G., Cimaz, R., & Caporali, R. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102523 · Cited by 454 · see citing works

Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review

Ortiz-Prado, E., Simbaña-Rivera, K., Gómez- Barreno, L., Rubio-Neira, M., Guaman, L. P., Kyriakidis, N. C., Muslin, C., Jaramillo, A. M. G., Barba-Ostria, C., Cevallos-Robalino, D., et al. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115094 · Cited by 458 · see citing works

Kinase inhibition in autoimmunity and inflammation

Zarrin, A. A., Bao, K., Lupardus, P., & Vucic, D. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0082-8 · Cited by 431 · see citing works

COVID-19 vaccines: The status and perspectives in delivery points of view

Chung, J. Y., Thone, M. N., & Kwon, Y. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.011 · Cited by 375 · see citing works

Psychological status and behavior changes of the public during the COVID-19 epidemic in China

Liu, X., Luo, W.-T., Li, Y., Li, C.-N., Hong, Z.-S., Chen, H.-L., Xiao, F., & Xia, J.-Y. (2020) · Infectious Diseases of Poverty · doi:10.1186/s40249-020-00678-3 · Cited by 375 · see citing works

Deep Learning applications for COVID-19

Shorten, C., Khoshgoftaar, T. M., & Furht, B. (2021) · Journal of Big Data · doi:10.1186/s40537-020-00392-9 · Cited by 350 · see citing works

Baricitinib restrains the immune dysregulation in patients with severe COVID-19

Bronte, V., Ugel, S., Tinazzi, E., Vella, A., De Sanctis, F., Canè, S., Batani, V., Trovato, R., Fiore, A., Petrova, V., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci141772 · Cited by 281 · see citing works

Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad

Ahmed, S., Zimba, O., & Gasparyan, A. Y. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05275-1 · Cited by 251 · see citing works

Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques

Hoang, T. N., Pino, M., Boddapati, A. K., Viox, E. G., Starke, C. E., Upadhyay, A. A., Gumber, S., Nekorchuk, M., Busman-Sahay, K., Strongin, Z., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.007 · Cited by 212 · see citing works

A critical overview of computational approaches employed for COVID-19 drug discovery

Muratov, E. N., Amaro, R., Andrade, C. H., Brown, N., Ekins, S., Fourches, D., Isayev, O., Kozakov, D., Medina-Franco, J. L., Merz, K. M., et al. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01065k · Cited by 206 · see citing works

Unleashing the power of generative AI in drug discovery

Gangwal, A., & Lavecchia, A. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.103992 · Cited by 195 · see citing works

COVID-19 revisiting inflammatory pathways of arthritis

Schett, G., Manger, B., Simon, D., & Caporali, R. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0451-z · Cited by 191 · see citing works

Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study

Rodriguez-Garcia, J. L., Sanchez-Nievas, G., Arevalo-Serrano, J., Garcia-Gomez, C., Jimenez-Vizuete, J. M., & Martinez-Alfaro, E. (2021) · Rheumatology · doi:10.1093/rheumatology/keaa587 · Cited by 112 · see citing works

Baricitinib in hospitalised patients with COVID-19: a meta-analysis of randomised controlled trials

Selvaraj, V., Finn, A., Lal, A., Khan, M. S., Dapaah-Afriyie, K., & Carino, G. P. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101489 · Cited by 101 · see citing works

DrugCentral 2023 extends human clinical data and integrates veterinary drugs

Avram, S., Wilson, T. B., Curpan, R., Halip, L., Borota, A., Bora, A., Bologa, C. G., Holmes, J., Knockel, J., Yang, J. J., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac1085 · Cited by 101 · see citing works

Molecular mechanisms and epidemiology of COVID-19 from an allergist’s perspective

Hosoki, K., Chakraborty, A., & Sur, S. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.033 · Cited by 63 · see citing works

Expert-Augmented computational drug repurposing identified baricitinib as a treatment for COVID-19

Smith, D. P., Oechsle, O., Rawling, M. J., Savory, E., Lacoste, A. M. B., & Richardson, P. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.709856 · Cited by 62 · see citing works

Artificial Intelligence in Small-Molecule Drug Discovery: A Critical Review of Methods, Applications, and Real-World Outcomes

Niazi, S. K. (2025) · Pharmaceuticals · doi:10.3390/ph18091271 · Cited by 61 · see citing works

Success stories of AI in drug discovery - where do things stand?

Mak, K.-K., Balijepalli, M. K., & Pichika, M. R. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.1985108 · Cited by 51 · see citing works

Trust and Trustworthiness in AI

Durán, J. M., & Pozzi, G. (2025) · Philosophy & Technology · doi:10.1007/s13347-025-00843-2 · Cited by 47 · see citing works

Fighting COVID-19 with Artificial Intelligence

Monteleone, S., Kellici, T. F., Southey, M., Bodkin, M. J., & Heifetz, A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1787-8_3 · Cited by 17 · see citing works

ОПЫТ ОЦЕНКИ ПОПУЛЯЦИОНОГО ИММУНИТЕТА К SARS-CoV-2 СРЕДИ НАСЕЛЕНИЯ ЛЕНИНГРАДСКОЙ ОБЛАСТИ В ПЕРИОД ЭПИДЕМИИ COVID-19Preprint

Popova, A. Y., Ezhlova, E. B., Melnikova, A. A., Istorik, O. A., Mosevich, O. S., Лялина, Л. В., Смирнов, В. С., Черный, М., Балабашыва, Н., Loginova, I. S., et al. (2020) · doi:10.21055/preprints-3111753 · Cited by 7 · see citing works

Перинатальные последствия COVID-19 (SARS-CoV-2): обзор литературы (часть I)

Жабченко, И. А., Gerevich, N. V., Kravtsova, Y. A., Сюдмак, О. Р., Коваленко, Т. Н., Бондаренко, Е. Н., & Lishchenko, I. S. (2022) · Репродуктивная медицина · doi:10.37800/rm.1.2022.7-14 · Cited by 3 · see citing works

Особенности сахароснижающей фармакотерапии у пациентов с SARS-CoV-2 (COVID-19)

Кухнина, Л. С., Сахарова, К. В., & Elina, D. (2021) · ТЕНДЕНЦИИ РАЗВИТИЯ НАУКИ И ОБРАЗОВАНИЯ · doi:10.18411/lj-04-2021-51

ПОПУЛЯЦИОННЫЙ ИММУНИТЕТ К ВИРУСУ SARS-CoV-2 СРЕДИ НАСЕЛЕНИЯ САНКТ-ПЕТЕРБУРГА В АКТИВНУЮ ФАЗУ ЭПИДЕМИИ COVID-19Preprint

Попова, А., Ezhlova, E. B., Melnikova, A. A., Башкетова, Н. С., Фридман, Р., Лялина, Л. В., Смирнов, В. С., Chkhindzheriya, I. G., Grechaninova, T. A., Agapov, K. A., et al. (2020) · doi:10.21055/preprints-3111752 · Cited by 12 · see citing works

Спонтанний пневмоторакс у хворих на нову коронавірусну хворобу SARS-CoV-2 COVID-19

Горолюк, А. Ю. (2022) · Шпитальна хірургія Журнал імені Л Я Ковальчука · doi:10.11603/2414-4533.2022.1.12929